Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha Radiation”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Not applicableLooking for participantsNCT05632913
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer

Who this might be right for
Recurrent Lung CancerLung Cancer
Alpha Tau Medical LTD. 10
Large-scale testing (Phase 3)Study completedNCT00169845
What this trial is testing

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Who this might be right for
Neoplasms
Laval University 540
Not applicableEnded earlyNCT03970967
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Who this might be right for
Breast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more
Alpha Tau Medical LTD. 1
Not applicableLooking for participantsNCT07256119
What this trial is testing

Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients

Who this might be right for
Prevention
Ain Shams University 40
Not applicableStudy completedNCT04377360
What this trial is testing

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Who this might be right for
Malignant Skin TumorSoft Tissue Tumor, Malignant
Alpha Tau Medical LTD. 10
Not applicableNot Yet RecruitingNCT06202339
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Who this might be right for
Carcinoma of the VulvaRecurrent Carcinoma of the Vulva
Alpha Tau Medical LTD. 10
Not applicableStudy completedNCT03353077
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Who this might be right for
Skin Squamous Cell Carcinoma
Alpha Tau Medical LTD. 28
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableLooking for participantsNCT06698458
What this trial is testing

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer
Alpha Tau Medical LTD. 50
Not applicableLooking for participantsNCT06202118
What this trial is testing

Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Who this might be right for
Breast CancerRecurrent Breast CancerBreast Carcinoma
Alpha Tau Medical LTD. 10
Not applicableStudy completedNCT04906070
What this trial is testing

Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

Who this might be right for
Breast CancerHead and Neck Cancer
Hekabio 14
Not applicableLooking for participantsNCT07221825
What this trial is testing

Low-Count Quantitative SPECT for Men Treated With Radium-223

Who this might be right for
Prostate CancerCancer of the Prostate
Washington University School of Medicine 38
Not applicableUnknownNCT04761146
What this trial is testing

A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer

Who this might be right for
Vulva Cancer, RecurrentVulvar Squamous Cell CarcinomaVulva Cancer
CCTU- Cancer Theme 10
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06710756
What this trial is testing

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more
Perspective Therapeutics 112
Testing effectiveness (Phase 2)Looking for participantsNCT06726161
What this trial is testing

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
RayzeBio, Inc. 590
Early research (Phase 1)Active Not RecruitingNCT07214961
What this trial is testing

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer (CRPC)Metastatic Castrate Resistant Prostate Cancer (mCRPC)
ARTBIO Inc. 80
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Large-scale testing (Phase 3)UnknownNCT01729663
What this trial is testing

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Who this might be right for
Cutaneous Melanoma
Laboratorio Pablo Cassara S.R.L. 108
Next Page